Baroness Jones of Whitchurch (Lab)

I am glad we are on the same page on all that. I now turn to the specifics of the amendments. I thank the noble Lords, Lord Freyberg and Lord Holmes, and the noble Viscount, Lord Camrose, for their amendments, and the noble Lord, Lord Lucas, for his contribution. As I said in the previous debate, I can reassure all noble Lords that if an area of research does not count as scientific research at the moment, it will not under the Bill. These provisions do not expand the meaning of scientific research. If noble Lords still feel unsure about that, I am happy to offer a technical briefing to those who are interested in this issue to clarify that as far as possible. Moreover, the Bill’s requirement for a reasonableness test will help limit the misuse of this definition more than the current UK GDPR, which says that scientific research should be interpreted broadly. We are tightening up the regulations. This is best assessed on a case-by- case basis, along with the ICO guidance, rather than automatically disqualifying or passing into our activity sectors by approval. Scientific research that is privately funded or conducted by commercial organisations can also have a life-changing impact. The noble Lord, Lord Markham, was talking earlier about health; issues such as the development of Covid vaccines are just one example of this. It was commercial research that was absolutely life-saving, at the end of the day.